Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users

Peter A. Selwyn, R. J. Carter, Ellie Schoenbaum, V. J. Robertson, R. S. Klein, M. F. Rogers

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

We studied decisions to continue or terminate pregnancy among human immunodeficiency virus (HIV)-seropositive (+) and -seronegative (-) intravenous drug users informed of HIV antibody status before 24 weeks' gestation. Fourteen (50%) of 28 HIV+ vs 16 (44%) of 36 HIV- women chose to terminate their pregnancies. In retrospective interviews, HIV+ women were more likely to have perceived their risk of perinatal HIV transmission to be greater than or equal to 50% and, among those who terminated pregnancy, to cite this concern as an important factor in their decision. However, decisions to terminate pregnancy were predicted more readily by pregnancy-related variables such as prior elective abortion, a negative emotional reaction to pregnancy, and whether the pregnancy had been unplanned. Women who were HIV+ and chosen to continue their pregnancies cited the desire for a child, religious beliefs, and family pressures as the most important factors in their decisions. Results indicate that while concerns about perinatal transmission of HIV may lead to decisions to terminate pregnancy in certain cases, there may be other determinants of pregnancy decisions in this population. Counseling of HIV-infected women must address not only perinatal transmission but also the sociocultured and behavioral context in which pregnancy decision making takes place.

Original languageEnglish (US)
Pages (from-to)3567-3571
Number of pages5
JournalJournal of the American Medical Association
Volume261
Issue number24
StatePublished - 1989

Fingerprint

Drug Users
HIV
Pregnancy
Antibodies
Religion
Counseling
Decision Making
Interviews
Pressure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. / Selwyn, Peter A.; Carter, R. J.; Schoenbaum, Ellie; Robertson, V. J.; Klein, R. S.; Rogers, M. F.

In: Journal of the American Medical Association, Vol. 261, No. 24, 1989, p. 3567-3571.

Research output: Contribution to journalArticle

@article{66da615fa9d84103a3eca645dbd33345,
title = "Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users",
abstract = "We studied decisions to continue or terminate pregnancy among human immunodeficiency virus (HIV)-seropositive (+) and -seronegative (-) intravenous drug users informed of HIV antibody status before 24 weeks' gestation. Fourteen (50{\%}) of 28 HIV+ vs 16 (44{\%}) of 36 HIV- women chose to terminate their pregnancies. In retrospective interviews, HIV+ women were more likely to have perceived their risk of perinatal HIV transmission to be greater than or equal to 50{\%} and, among those who terminated pregnancy, to cite this concern as an important factor in their decision. However, decisions to terminate pregnancy were predicted more readily by pregnancy-related variables such as prior elective abortion, a negative emotional reaction to pregnancy, and whether the pregnancy had been unplanned. Women who were HIV+ and chosen to continue their pregnancies cited the desire for a child, religious beliefs, and family pressures as the most important factors in their decisions. Results indicate that while concerns about perinatal transmission of HIV may lead to decisions to terminate pregnancy in certain cases, there may be other determinants of pregnancy decisions in this population. Counseling of HIV-infected women must address not only perinatal transmission but also the sociocultured and behavioral context in which pregnancy decision making takes place.",
author = "Selwyn, {Peter A.} and Carter, {R. J.} and Ellie Schoenbaum and Robertson, {V. J.} and Klein, {R. S.} and Rogers, {M. F.}",
year = "1989",
language = "English (US)",
volume = "261",
pages = "3567--3571",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "24",

}

TY - JOUR

T1 - Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users

AU - Selwyn, Peter A.

AU - Carter, R. J.

AU - Schoenbaum, Ellie

AU - Robertson, V. J.

AU - Klein, R. S.

AU - Rogers, M. F.

PY - 1989

Y1 - 1989

N2 - We studied decisions to continue or terminate pregnancy among human immunodeficiency virus (HIV)-seropositive (+) and -seronegative (-) intravenous drug users informed of HIV antibody status before 24 weeks' gestation. Fourteen (50%) of 28 HIV+ vs 16 (44%) of 36 HIV- women chose to terminate their pregnancies. In retrospective interviews, HIV+ women were more likely to have perceived their risk of perinatal HIV transmission to be greater than or equal to 50% and, among those who terminated pregnancy, to cite this concern as an important factor in their decision. However, decisions to terminate pregnancy were predicted more readily by pregnancy-related variables such as prior elective abortion, a negative emotional reaction to pregnancy, and whether the pregnancy had been unplanned. Women who were HIV+ and chosen to continue their pregnancies cited the desire for a child, religious beliefs, and family pressures as the most important factors in their decisions. Results indicate that while concerns about perinatal transmission of HIV may lead to decisions to terminate pregnancy in certain cases, there may be other determinants of pregnancy decisions in this population. Counseling of HIV-infected women must address not only perinatal transmission but also the sociocultured and behavioral context in which pregnancy decision making takes place.

AB - We studied decisions to continue or terminate pregnancy among human immunodeficiency virus (HIV)-seropositive (+) and -seronegative (-) intravenous drug users informed of HIV antibody status before 24 weeks' gestation. Fourteen (50%) of 28 HIV+ vs 16 (44%) of 36 HIV- women chose to terminate their pregnancies. In retrospective interviews, HIV+ women were more likely to have perceived their risk of perinatal HIV transmission to be greater than or equal to 50% and, among those who terminated pregnancy, to cite this concern as an important factor in their decision. However, decisions to terminate pregnancy were predicted more readily by pregnancy-related variables such as prior elective abortion, a negative emotional reaction to pregnancy, and whether the pregnancy had been unplanned. Women who were HIV+ and chosen to continue their pregnancies cited the desire for a child, religious beliefs, and family pressures as the most important factors in their decisions. Results indicate that while concerns about perinatal transmission of HIV may lead to decisions to terminate pregnancy in certain cases, there may be other determinants of pregnancy decisions in this population. Counseling of HIV-infected women must address not only perinatal transmission but also the sociocultured and behavioral context in which pregnancy decision making takes place.

UR - http://www.scopus.com/inward/record.url?scp=0024371171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024371171&partnerID=8YFLogxK

M3 - Article

C2 - 2724503

AN - SCOPUS:0024371171

VL - 261

SP - 3567

EP - 3571

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 24

ER -